Isolated limb infusion with melphalan and actinomycin D in melanoma patients: factors predictive of acute regional toxicity

Factors Predictive of Acute Regional Toxicity After Isolated Limb Infusion with Melphalan and Actinomycin D in Melanoma Patients

(2009) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

Predictive Factors of Regional Toxicity and Serum Creatine Phosphokinase Levels After Isolated Limb Infusion for Melanoma: A Multi-Institutional Analysis

(2009) Alfredo A. Santillan et al.   ANNALS OF SURGICAL ONCOLOGY

A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US

(2009) Georgia M. Beasley et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Isolated Limb Infusion for In-Transit Malignant Melanoma of the Extremity: A Well-Tolerated but Less Effective Alternative to Hyperthermic Isolated Limb Perfusion

(2008) Georgia M. Beasley et al.   ANNALS OF SURGICAL ONCOLOGY

Outcomes Following Isolated Limb Infusion for Melanoma. A 14-Year Experience

(2008) Hidde M. Kroon et al.   ANNALS OF SURGICAL ONCOLOGY

Current status of isolated limb infusion with mild hyperthermia for melanoma

(2008) John F. Thompson et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Pharmacokinetics of Regional Therapy: Isolated Limb Infusion and Other Low Flow Techniques for Extremity Melanoma

(2008) Peter C.A. Kam et al.   Surgical Oncology Clinics of North America